Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome

Growth Hormone and IGF Research

Volumn 16, Issue SUPPL., 2006, Pages 91-97

  Davenport, Marsha L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Growth hormone; Timing; Transdermal estradiol; Turner syndrome

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; ESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; GROWTH HORMONE; SOMATOMEDIN C;

ANALYSIS OF COVARIANCE; ARTICLE; BODY HEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GIRL; GROWTH DISORDER; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PUBERTY; TREATMENT DURATION; TURNER SYNDROME;

ADMINISTRATION, CUTANEOUS; AGE FACTORS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; ESTRADIOL; FEMALE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; TURNER SYNDROME;

EID: 33745183141     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.04.002     Document Type: Article

References (38)

1. Lyon A.J., Preece M.A., and Grant D.B. Growth curve for girls with Turner syndrome. Arch. Dis. Child. 60 (1985) 932-935
2. Van Pareren Y.K., Duivenvoorden H.J., Slijper F.M., Koot H.M., Drop S.L., and de Muinck Keizer-Schrama S.M. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm. Res. 63 (2005) 238-244
3. Pasquino A.M., Passeri F., Pucarelli I., Segni M., and Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J. Clin. Endocrinol. Metab. 82 (1997) 1810-1813
4. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J. Endocrinol. 185 (2005) 223-234
5. Frank G.R. Role of estrogen and androgen in pubertal skeletal physiology. Med. Pediatr. Oncol. 41 (2003) 217-221
6. Cacciari E., and Mazzanti L. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. J. Clin. Endocrinol. Metab. 84 (1999) 4510-4515
7. Massa G., Maes M., Heinrichs C., Vandeweghe M., Craen M., and Vanderschueren-Lodeweyckx M. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome. Clin. Endocrinol. (Oxf) 38 (1993) 253-260
8. Chernausek S.D., Attie K.M., Cara J.F., Rosenfeld R.G., and Frane J. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J. Clin. Endocrinol. Metab. 85 (2000) 2439-2445
9. The Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian Randomized Controlled Trial. J. Clin. Endocrinol. Metab. 90 (2005) 3360-3366
10. Soriano-Guillen L., Coste J., Ecosse E., et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J. Clin. Endocrinol. Metab. 90 (2005) 5197-5204
11. Rosenfield R.L., Devine N., Hunold J.J., Mauras N., Moshang Jr. T., and Root A.W. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 90 (2005) 6424-6430
12. Rosenfeld R.G., Attie K.M., Frane J., et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J. Pediatr. 132 (1998) 319-324
13. Van Pareren Y.K., de Muinck Keizer-Schrama S.M., Stijnen T., et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J. Clin. Endocrinol. Metab. 88 (2003) 1119-1125
14. Pasquino A.M., Pucarelli I., Segni M., Tarani L., Calcaterra V., and Larizza D. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J. Endocrinol. Invest. 28 (2005) 350-356
15. Davenport M.L., Punyasavatsut N., Stewart P.W., Gunther D.F., Savendahl L., and Sybert V.P. Growth failure in early life: an important manifestation of Turner syndrome. Horm. Res. 57 (2002) 157-164
16. Rongen-Westerlaken C., Corel L., van den Broeck J., et al. Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr. 86 (1997) 937-942
17. Karlberg J., Albertsson-Wikland K., Nilsson K.O., Ritzen E.M., and Westphal O. Growth in infancy and childhood in girls with Turner's syndrome. Acta Paediatr. Scand. 80 (1991) 1158-1165
18. Even L., Cohen A., Marbach N., et al. Longitudinal analysis of growth over the first 3 years of life in Turner's syndrome. J. Pediatr. 137 (2000) 460-464
19. Savendahl L., and Davenport M.L. Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J. Pediatr. 137 (2000) 455-459
20. M.L. Davenport, C.A. Quigley, C.G. Bryant, et al., Effect of early growth hormone (GH) treatment in very young girls with Turner syndrome (TS). Presented at: 7th Joint ESPE/LWPES Meeting; Lyon, France; 2005.
21. Rosenfeld R.G., Frane J., Attie K.M., et al. Six-years results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome [see comments]. J. Pediatr. 121 (1992) 49-55
22. Kiess W., Conway G., Ritzen M., et al. Induction of puberty in the hypogonadal girl-practices and attitudes of pediatric endocrinologists in Europe. Horm. Res. 57 (2002) 66-71
23. Ankarberg-Lindgren C., Elfving M., Wikland K.A., and Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J. Clin. Endocrinol. Metab. 86 (2001) 3039-3044
24. Kastrup K.W. Growth and development in girls with Turner's syndrome during early therapy with low doses of estradiol. Acta Endocrinol. Suppl. (Copenh) 279 (1986) 157-163
25. Bhavnani B.R. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc. Soc. Exp. Biol. Med. 217 (1998) 6-16
26. Leung K.C., Johannsson G., Leong G.M., and Ho K.K.Y. Estrogen regulation of growth hormone action. Endocr. Rev. 25 (2004) 693-721
27. de Lignieres B., Basdevant A., Thomas G., et al. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. J. Clin. Endocrinol. Metab. 62 (1986) 536-541
28. Weissberger A.J., Ho K.K., and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72 (1991) 374-381
29. Janssen Y.J.H., Helmerhorst F., Frolich M., and Roelfsema F. A switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J. Clin. Endocrinol. Metab. 85 (2000) 464-467
30. Wolthers T., Hoffman D.M., Nugent A.G., Duncan M.W., Umpleby M., and Ho K.K.Y. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E1191-E1196
31. Mah P.M., Webster J., Jonsson P., Feldt-Rasmussen U., Koltowska-Haggstrom M., and Ross R.J. Estrogen replacement in women of fertile years with hypopituitarism. J. Clin. Endocrinol. Metab. 90 (2005) 5964-5969
32. Piippo K.S., Lenko H., Kainulainen P., and Sipila I. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. Obstet. Gynecol. Surv. 60 (2005) 102-103
33. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J. Endocrinol. 185 (2005) 223-234
34. Frank G.R. Role of estrogen and androgen in pubertal skeletal physiology. Med. Pediatr. Oncol. 41 (2003) 217-221
35. Ross J.L., Roeltgen D., Feuillan P., Kushner H., and Cutler Jr. G.B. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 83 (1998) 3198-3204
36. Gravholt C.H., Naeraa R.W., Nyholm B., et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 21 (1998) 1062-1070
37. Ostberg J.E., Thomas E.L., Hamilton G., Attar M.J., Bell J.D., and Conway G.S. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J. Clin. Endocrinol. Metab. 90 (2005) 2631-2635
38. Elsheikh M., Hodgson H.J., Wass J.A., and Conway G.S. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin. Endocrinol. (Oxf) 55 (2001) 227-231